Associated equity: Worldwide Healthcare Trust
Worldwide Healthcare Trust is a specialist investment trust that invests in the global healthcare sector, with the objective of achieving a high level of capital growth. Gearing and derivative transactions are used to enhance capital returns and mitigate risk. Performance is measured against the MSCI World Health Care Index (sterling adjusted).
Worldwide Healthcare Trust — 3 videos in collection
In this episode, Dr Arron Aatkar, director and analyst covering healthcare and investment companies at Edison, discusses Worldwide Healthcare Trust (WWH), a specialist trust investing across the global healthcare sector and managed by OrbiMed. Arron covers WWH’s recent leadership transition, with Trevor Polischuk becoming lead manager alongside new co-manager Geoff Hsu following Sven Borho’s departure after more than 30 years at the helm. He also discusses the trust’s strong recovery through FY26 and into June 2026, with NAV and share price total returns of 30.6% and 29.9% over the 12 months to end-June, well ahead of the benchmark. This is driven by the trust’s biotechnology allocation, M&A activity including its proprietary Biotech M&A Basket, and a standout contribution from Eli Lilly. Arron also touches on WWH’s narrowing discount to NAV, its 0.9% ongoing charge and the trust’s continued focus on innovation-led opportunities across oncology, obesity and diagnostics.
Listen on your preferred podcast player below:
About Uncovering Trusts: Uncovering Trusts is a podcast run by Edison analysts, which is released every two weeks. Subscribe to hear analyst interviews on how investment trusts maximise returns while managing risks for investors.